CREO vs. NIOX, EKF, IUG, NCYT, POLX, BELL, IHC, MHC, AVO, and RUA
Should you be buying Creo Medical Group stock or one of its competitors? The main competitors of Creo Medical Group include NIOX Group (NIOX), EKF Diagnostics (EKF), Intelligent Ultrasound Group (IUG), Novacyt (NCYT), Polarean Imaging (POLX), Belluscura (BELL), Inspiration Healthcare Group (IHC), MyHealthChecked (MHC), Advanced Oncotherapy (AVO), and RUA Life Sciences (RUA). These companies are all part of the "medical devices" industry.
Creo Medical Group vs.
Creo Medical Group (LON:CREO) and NIOX Group (LON:NIOX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, community ranking, valuation, profitability, risk, dividends, earnings and analyst recommendations.
Creo Medical Group received 105 more outperform votes than NIOX Group when rated by MarketBeat users. However, 100.00% of users gave NIOX Group an outperform vote while only 67.52% of users gave Creo Medical Group an outperform vote.
56.1% of Creo Medical Group shares are owned by institutional investors. Comparatively, 35.2% of NIOX Group shares are owned by institutional investors. 22.4% of Creo Medical Group shares are owned by insiders. Comparatively, 46.7% of NIOX Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Creo Medical Group has a beta of 0.86, suggesting that its share price is 14% less volatile than the S&P 500. Comparatively, NIOX Group has a beta of 0.92, suggesting that its share price is 8% less volatile than the S&P 500.
In the previous week, NIOX Group had 1 more articles in the media than Creo Medical Group. MarketBeat recorded 1 mentions for NIOX Group and 0 mentions for Creo Medical Group. Creo Medical Group's average media sentiment score of 0.00 equaled NIOX Group'saverage media sentiment score.
NIOX Group has a net margin of 30.00% compared to Creo Medical Group's net margin of -73.93%. NIOX Group's return on equity of 13.52% beat Creo Medical Group's return on equity.
NIOX Group has higher revenue and earnings than Creo Medical Group. Creo Medical Group is trading at a lower price-to-earnings ratio than NIOX Group, indicating that it is currently the more affordable of the two stocks.
Summary
NIOX Group beats Creo Medical Group on 12 of the 14 factors compared between the two stocks.
Get Creo Medical Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for CREO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Creo Medical Group Competitors List
Related Companies and Tools
This page (LON:CREO) was last updated on 2/2/2025 by MarketBeat.com Staff
